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The EGFR pathway is critical for cell fate speciﬁcation throughout the development of several organisms.
Here we identiﬁed in sea urchin an EGFR-related antigen maternally expressed and showing a dynamic
pattern of localization during development. To investigate the role played by the EGFR in Paracentrotus
lividus development we blocked its activity by using the EGFR kinase inhibitor AG1478. This treatment
produces decrease of EGFR phosphorylation, and embryos with various defects especially in the endome-
soderm territory until to obtain an animalized phenotype. These effects are rescued by the addition of
TGF-a, an EGFR ligand. The role played by EGFR-like along the animal/vegetal axis was also detected, after
AG1478 treatment, by the extended distribution of HE and decreased nuclearization of b-catenin in veg-
etal cells. Moreover, inhibition of EGFR-like reduced ERK phosphorylation, necessary for cell fate speciﬁ-
cation in the micromeres and their derivates. Taken together these results indicate that EGFR-like activity
is required both for A/V axis formation and endomesoderm differentiation.
 2008 Published by Elsevier Inc.Intracellular signalling plays a signiﬁcant role in the regulation
of biological processes such as cell proliferation, differentiation,
migration and survival. Signals can either stimulate or inhibit a
speciﬁc process, and the same signal can have different effects dur-
ing different development events, even within the same organism.
Moreover, in order to generate speciﬁc responses, distinct signals
can cross-talk between one another, and tissue-speciﬁc down-
stream signalling components can also be employed.
The epidermal growth factor receptor (EGFR)1 is a transmem-
brane receptor tyrosine kinase (RTK) that acts through the Ras/
MAP, or PLCc–PKC, or IP3R or cyclin-dependent cascades and medi-
ates various inductive signalling events in several tissues to regulate
normal embryonic development and adult differentiation [1–4]. It is
an important element in other signalling pathways, and its role is
not exclusively limited to that of the EGF reception, but is consideredElsevier Inc.
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nication network switching point [5]. EGFR is, indeed, subjected to
regulation and modulation by multiple ligands. The known ligands
for EGFR include epidermal growth factor (EGF), transforming
growth factor-a (TGF-a), amphiregulin (AR), epiregulin (EREG), b-cel-
lulin (BTC), and heparin-binding EGF (HB-EGF) [6]. Such ligands
share a common EGF domain, permitting them to form a speciﬁc sec-
ondary structure motif, while they share no or very little homology
outside this domain. Sequences inside and outside the EGF domain
determine the speciﬁcity of any given ligand. Signalling via EGFR is
important during the development of mice, fruit ﬂies and nema-
todes, and its mutation or enhancement leads to human tumor
progression.
A family of EGF receptors exists in mammals, including ErbB1,
ErbB2, ErbB3 and ErbB4. Ligand binding to ErB receptors induces
the formation of receptor homo- and heterodimers and activation
of speciﬁc signalling pathways [2,7]. Overexpression of this recep-
tor and its family members has been correlated with development
of different human tumors [8].
EGFR in Drosophila is present at many different stages of devel-
opment and its signalling activity is modulated by activating or
inhibiting its four ligands gurken, spitz, vein, argos [9–14]. Further,
it has been demonstrated that EGFR controls invagination of epi-
thelia in a process called ‘‘boundary smoothing”, that permits to
convert ﬂat epithelium into three-dimensional organs [15].
In Caenorhabditis elegans, the EGFR family member LET-23 is
present in several tissues and is required in vulva differentiation,
acting on tissue-speciﬁc transcription factor such as LIN-31 [16–
18]. A recent discovery has demonstrated that activation of EGFR
Fig. 1. Identiﬁcation of an EGFR-like related antigen by Western blotting after SDS–
PAGE analysis. Proteins extracted from P. lividus unfertilized (UV) and fertilized eggs
(FE), 16-cell stage (16), morula (M) blastula (B), gastrula (G), prism (P) and pluteus
(Pl) were blotted and the membrane was incubated with anti-EGFR (EGFR) human
polyclonal antibody. The arrows on the right indicate molecular weights.
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state. This pathway modulates the termination of locomotion that
normally occurs during the lethargic period that precedes larval
molting. Thus, EGF signalling plays a role in the regulation of
behavioral quiescence [19].
The sea urchin embryo is a regulative developmental system
whose patterning is established though a combination of maternal
determinants and signalling among cells and/or tissues [20]. Ecto-
derm, mesoderm and endoderm fates along the A/V axis are deter-
mined by an inductive process, starting from the vegetal half of the
embryo and initiated by cell-autonomous activation of canonical
Wnt signalling in micromeres. Thus, speciﬁc signals constitute an
input to transcribe speciﬁc spatial regulatory genes that are orga-
nized in network [20,21].
The sea urchin represents a good model system for studying
changes in developmental programming due to the perturbation
of speciﬁc signalling pathways. Two epidermal growth factor
(EGF)-relate genes from Strongilocentrotus purpuratus, which en-
code putative secreted proteins have been cloned and character-
ized, suggesting the presence of a receptor [22–24]. Moreover,
the presence of EGFR in the sea urchin species Lytechinus variegatus
has been suggested by the recognition of a speciﬁc protein by anti-
bodies against the mammalian receptor, and its involvement in gut
and spicule formation has been demonstrated [25].
In an effort to identify the signalling pathways involved in early
Paracentrotus lividus development, particularly, the moment in
which cells begin to acquire distinct tissue-speciﬁc properties,
we decided to investigate the possible involvement of an EGFR-like
in this role by inhibiting its function with AG1478 [26]. Here we
show that EGFR-like activity is required both for A/V axis forma-
tion and supporting the roles played by the micromere–PMC line-
age in order to achieve correct endomesoderm development.
Materials and methods
Morphogenetic assay
Eggs from sea urchins (P. lividus) were demembranated by fertilization in 2 mM
PABA. Approximately 1000 embryos were added to artiﬁcial sea water (ASW) con-
taining Tyrphostin AG 1478 (Sigma) diluted from stock in DMSO at doses varying
from 5 to 12.5 lM in 8-well plates. AG1478 was used at 5 lM, 7.5 lM or 10 lM in
most experiments. Embryos were cultured in the presence of AG1478 until the
7th cleavage stage (about 5 h post-fertilization), washed three times in ASW and
cultured for 48 h (pluteus stage). In some experiments, in which localization of b-
catenin or ERK was investigated, the embryos were allowed to develop with the
compound until the 64-cell stage or mesenchyme blastula, respectively, in agree-
ment with their temporal/spatial expression pattern. For TGF-a experiments
20 ng/ml TGF-a (SIGMA) was added together 10 lM AG1478 before ﬁrst cleavage
and the embryos were cultured for 48 h. The effect on morphogenesis was ob-
served, depending on the experiment, at different times of development by micro-
scopic inspection, and photographed using a Zeiss Axioscop2. To improve
observation, in some cases the embryos were squashed and observed them differ-
ential interference (DIC) microscopy. In all experiments, embryos were also cul-
tured in ASW or in ASW containing DMSO as controls, and assays were repeated
three times with different batches.
Protein extraction and Western blotting
Total proteins were prepared by pulsed sonication for 90 s in solubilizing buffer
(50 mM Tris–HCl pH 8.0, 150 mM NaCl, 0.5% Triton X-100, 2 mM PMSF, 10 lg/ml
protease inhibitor, 1 mM Na3VO4, 1 mM NaF) from treated or control eggs and at
different embryonic stages in ice. The lysates were centrifuged at 15,000g for
30 min at 4 C and the supernatants used for Western blotting. Protein samples
(50–100 lg) were electrophoretically separated using 4–20% gradient SDS–PAGE
gels (NuPAGE, Invitrogen) and transferred onto nitrocellulose ﬁlters for immuno-
blotting. After blocking in 3% BSA in PBST, the Western blot was incubated with
anti-EGFR primary antibodies (sc-120, Santa-Cruz Biotech.) (1:500), or anti-phos-
photyrosine (clone 4G10, Upstate) (1:500), or anti-a-tubulin (clone B-5-1-2, Sigma)
(1:2000) overnight at 4 C. Primary antibodies were detected using the ECL chemi-
luminescence kit (Amersham) according to the manufacturer’s instructions, and
using secondary antibodies conjugated to horseradish peroxidase (1:1500)
(Amersham).Whole mount immunohistochemistry
Control and treated P. lividus embryos described above were collected at differ-
ent times of development, depending on the experiments. The samples were ﬁxed
in 2% formaldehyde in sea water, permeabilized at 20 C in methanol and rehy-
drated in PBS. Immunohistochemistry was carried out according to Romancino
et al. [27]. For immunoreactions, the primary antibodies anti-EctoV (1:20),
anti-Endo1 (1:20), anti-Ig8 (1:20), anti-H295 (1:5), b-catenin (gift of D. McClay)
(1:500), anti-HE (gift of C. Gache) (1:200), anti-EGFR (1:25), and anti-dephosphoryl-
ated ERK1&2 (Sigma) (1:400) were incubated overnight at 4 C. Secondary antibod-
ies were: for anti-EctoV, anti-Ig8, anti-mouse Cy3-conjugate, for anti-Endo1,
anti-mouse FITC-conjugate, for anti-b-catenin, anti-guinea pig FITC-conjugate, for
anti-HE, anti-rabbit Cy3-conjugate (all from Jackson ImmunoResearch). Secondary
antibodies described above were diluted 1:100 and incubated for about 1 h at room
temperature. When anti-EctoV, anti-Ig8, anti-Endo1, anti-b-catenin, anti-HE were
used, the secondary antibodies were anti-mouse Cy3-conjugate, anti-mouse
FITC-conjugate, anti-guinea pig FITC-conjugate, anti-rabbit Cy3-conjugate (Jackson
ImmunoResearch), respectively. The secondary antibodies described above were
diluted 1:100 and incubated for about 1 h at room temperature. In order to detect
EGFR, anti-ERK and H295 antigens, anti-mouse AP-conjugate (Sigma) (1:500) or
anti-mouse HRP-conjugate (Sigma) (1:150) secondary antibodies were incubated
for about 1 h at room temperature and then washed with PBST. Chromogenic
detection was carried out in AP buffer (150 mM NaCl, 100 mM Tris–HCl pH 9.5,
25 mM MgCl2, 5% polyvinylalcohol, 1 mM levamisole) with BCIP and NBT (Roche)
or in DAB color reaction (10 ml Tris–HCl 50 mM pH 6.8, 5 mg Diaminobenzidine,
10 ll 30% H2O2). Finally, the eggs and embryos were resuspended in 80% glycerol
in PBS and examined by microscopic inspection and photographed using a Zeiss
Axioscop2 plus for DIC images. Epiﬂuorescence was examined by microscopic
inspection using a Leica DHL microscope and recorded photographically.
Results
EGFR is expressed during P. lividus development
The recently available draft of the genome sequence of
S. purpuratus demonstrates that EGFR exists in the sea urchin as
a single copy gene [28,29]. To ascertain the expression of the puta-
tive EGFR ortholog in P. lividuswe extracted proteins from different
developmental stages, separated them by SDS–PAGE and blotted
them. The blot was incubated with human EGFR primary antibody.
A band of the approximate size of known EGFR (180 kDa) was pres-
ent throughout P. lividus development, suggesting that the anti-
body against the human EGFR speciﬁcally cross-reacts with a
related P. lividus EGF receptor antigen, that we called EGFR-like
(Fig. 1). We decided to analyse the spatial distribution of this anti-
gen during sea urchin development (Fig. 2). Immunolocalization of
EGFR-like reveals its presence both on the cell surface and in the
cytoplasm of the egg (2A), and it maintains this ubiquitous pres-
ence in all the blastomeres until the 16-cell stage (2B). Instead,
at the 32-cell stage, we found a reduced level of EGFR-like staining
in micromeres (2C) and at the 64-cell stage it is absent in the small
micromeres (2D). Moreover, we observed a large amount of this
receptor in the parts of the cells directed towards the blastocoel
cavity. At early blastula stage, the pattern of the stained cells
resembled that of PMC precursors (2E and F). Staining of PMC con-
tinues to be detected during ingression at mesenchyme blastula
and at this point it is possible to observe it on the basal side and
in some apical ectodermal cells of the embryo (2G). At late gastrula
stage, the cells at the bottom and at the top of the archenterons
and the SMC are stained (2H). At pluteus stage, staining is observa-
Fig. 2. Expression of EGFR-like during P. lividus development. (A–I) Whole mount immunolocalization using an anti-EGFR antibody. (A) Egg, (B) 16-cell stage, (C) 32-cell stage,
(D) 64-cell stage, (E) early blastula vegetal view, (F) early blastula, (G) mesenchyme blastula, (H) late gastrula, (I) pluteus.
Fig. 3. Effect of AG1478 on EGFR-like phosphorylation. P. lividus fertilized eggs
were incubated with 5 lM (5), 7.5 lM (7.5), 10 lM (10), 12.5 lM (12.5), AG1478 or
without AG1478 (C). After 40 min of incubation, proteins were extracted from the
different samples and after SDS–PAGE the blot was incubated with anti-phospho-
tyrosine (PTYR). Molecular weights indicated on the right. The blot was normalized
using anti-a-tubulin (a-TUB).
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(2I). These observations suggest that EGFR-like could play a role in
the transmission of signals for the speciﬁcation of determinate cell
types.
Inhibition of EGFR-like receptor provokes changes in P. lividus
development
In order to obtain some information about the role of the EGF
receptor in P. lividus developmental events, we used AG1478, a
tyrosine kinase inhibitor of the tyrphostin class that selectively
blocks autophosphorylation of EGFR [26]. Autophosphorylation of
receptors, following growth factor binding, creates speciﬁc phos-
phorylated tyrosine residues that serve as docking areas for down-
stream activated signal transducers, thus it is the starting point for
a cascade of events. In order to examine whether a compound such
as AG1478 has any effect on the phosphorylation of EGFR-like pro-
tein, fertilized P. lividus eggs were incubated with different concen-
trations of AG1478. Proteins extracted after 40 min of incubation
were separated by SDS–PAGE and blotted. After incubation with
anti-phosphotyrosine antibodies we observed a decrease in the
phosphorylation of a band of 180 kDa inversely proportional to
the increase in the drug concentration (Fig. 3). The same blot was
incubated with anti-EGFR and we observed that the bands coin-
cided with the previous (data not shown). The signal was quanti-
ﬁed by comparison with tubulin after scanning and densitometry
of the signal obtained following immunoblotting (data not shown).
In order to investigate when and where EGFR signalling is re-
quired, we analyzed the effect of blocking this signalling pathway
on P. lividus early development. Fertilized eggs were incubatedwithdifferent concentrations of AG1478 varying from 5 to 12.5 lMup to
the 7th cleavage stage, then the embryos were washed and allowed
to develop until control embryos, with or without DMSO, had
reached the pluteus stage (Fig. 4A). Depending on the dose concen-
tration, the embryos showed different morphologies with respect
to controls (Fig. 4B–D). At lower drug concentrations the majority
of the embryos showed no visible effects on development, and only
a few showed an enlarged oral ectoderm. At higher concentration of
AG1478, embryos displayed a range of phenotypes. At 7.5 lM, about
47% of the embryos arrested at the mid gastrula stage, at 10 lM
Fig. 4. Paracentrotus lividus embryos are sensitive to AG1478 treatment in a dose-dependent manner. (A) Altered morphology of embryos cultured in the presence of 5 lM
(5 lM), 7.5 lM (7.5 lM), 10 lM (10 lM), AG1478 until the 7th cleavage stage and allowed to develop to 48 h. Control embryos cultured for 48 h until pluteus stage (control).
Representative embryos from a range of similar phenotypes are shown in all the pictures. Pluteus (pluteus squashed) and embryos (embryos squashed) treated with AG1478
squashed on the slide (embryos squashed). (B) Embryos untreated (control) or treated with AG1478 (AG1478) or with AG1478 together TGF-a (AG1478–TGF-a). The blue
arrows indicate the spicules, the red arrows indicate the pigmented cells.
Table 1
AG1478 produces altered P. lividus phenotypes.
Treatments (%)a
Morphology Controlb 5 lM
Tyrphostin
AG1478
7.5 lM
Tyrphostin
AG1478
10 lM
Tyrphostin
AG1478
12.5 lM
Tyrphostin
AG1478
Normal
plutei
98 76 46 0.5
Occluded
small
pluteic
1 13 23 15 100 M.B.
arrested and
degenerated
Occluded
prismsd
0 7 16 29
Occluded
blastulae
1 4 15 55.5
a P. lividus grown in the AG1478 at indicated concentration until 7th cleavage
after washed three times and cultured for 2–3 days at 20 C. The results were taken
from three different duplicate experiments.
b An equal amount of DMSO as highest concentration of AG1478 was added to
control embryos.
c Small plutei with blastocoels ﬁlled with some cells and large oral hood.
d Small prims with blastocoels ﬁlled with some cells, small gut that never touch
the archenteron roof and oral hood was absent.
e Blastulae ﬁlled with cells and without gut and oral hood.
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These embryos lacked archenterons, primary mesenchyme-derived
spicules were very small, abnormal or absent, secondary mesen-
chyme-derived pigment cells were in a decreased number. More-
over, these embryos had a cuboidal epithelium with extended cilia
and resembled the features of animalized embryos. At 12.5 lM the
embryos were degenerated. All data are summarized in Table 1. To
better highlight the alteration on spicules and pigment cells the em-
bryoswereobservedafter squashing. Threedifferentphenotypesare
represented in Fig. 4. Spicules are smaller or absent, and the number
of pigment cells progressively lower with respect to the controls,
suggesting that EGFR-like signalling is requiredbefore the7th cleav-
age stage and for the cell lineage of the large micromeres. Further-
more, to have more evidence that the drug inhibits signalling
starting from EGFR-like antigen, we incubated embryos before ﬁrst
cleavage with both AG1478 and TGF-a, a canonical ligand of EGFR,
and already utilized for similar experiments by other authors
[25,30]. As shown in Fig. 4B, TGF-a has been able to rescue AG1748
disrupted/developmental arrested embryos and to recover also spi-
culogenesis. The obtained result suggests that TGF-a has antagon-
ised the drug effect.
Alteration of tissue-speciﬁc marker expression after incubation with
AG1478
In order to investigate which territories have been altered after
incubation of the embryos with the different concentrations ofAG1478, we examined these embryos with lineage-speciﬁc mark-
ers (Fig. 5). We utilized both EctoV (5A) and UH295 (5D) as oral
ectoderm markers [31], Ig8 as a primary mesenchyme cell marker
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scribed previously, the embryos failed to complete morphogenesis
and, depending on drug concentration, showed progressively de-
creased formation of vegetal derived structures. According to this
result the Ig8 mesenchyme cell (5H and I) and the Endo1 endo-
derm cell (5M and N) markers, detected at 24 and 48 h of develop-
ment respectively, showed decreased expression as the
concentration of AG1478 at which they were incubated increased.
Instead, EctoV, was expressed both in the thick epithelium, corre-
sponding to oral ectoderm, and in other cells inside and through-
out the surface of the embryoids (5B and C). The same result was
obtained when we utilized anti-UH295, an antibody that speciﬁ-
cally recognizes an epitope in ciliary band of the thickened epithe-Fig. 5. Immunolocalization of tissue lineage markers after treatment with AG1478.
Control embryos at 48 h of development incubated with anti-EctoV (A), anti-UH295
(D), anti-EndoI (L) or at 24 h of development incubated with anti-Ig8 (G). P. lividus
embryos cultured with increasing amounts (5, 7.5, 10 lM) of AG1478 up to the 7th
cleavage stage and allowed to developed to 48 h and incubated with anti-EctoV (B
and C), anti-UH295 (E and F), anti-EndoI (M and N) or allowed to develop to 24 h
and incubated with anti-Ig8 (H and I). (d) A detail of UH295 localization.lium (5E and F). These data support our previous morphological
observations and indicate that by blocking EGFR signalling, the em-
bryos develop an animalized phenotype with defects in A/V axis
formation.
HE expression in embryos treated with AG1478
The hatching enzyme gene (HE) is a one of the earliest known
genes activated following P. lividus fertilization and is expressed
transiently during cleavage [34]. HE is normally expressed in a re-
gion corresponding to the presumptive ectoderm. By chemical
treatment or experimental manipulation of speciﬁc genes it en-
large or restrict its localization along the A/V axis making it a use-
ful early marker in the identiﬁcation of vegetalized or animalized
phenotypes [35–37]. Hence, in order to support our morphological
observations described previously, and to investigate the possibil-
ity that EGFR-like signalling is required in gene expression of A/V
determinants during early development, we monitored the spatial
expression of HE in embryos treated with increasing amounts of
AG1478 and cultured them until control embryos reached the
hatching blastula stage (Fig. 6). Depending on the doses used, the
size of the territory in which the HE protein is detected increases
with respect to the control embryos (6B–D and D0). This effect is
concentration dependent, thus, when the concentration of the
compound increases a greater number of cells express HE indicat-
ing that the ectoderm/endoderm border along the A/V axis has
been altered.
Effect of EGFR on b-catenin nuclearisation
During early stages, sea urchin embryos display a graded distri-
bution of nuclear b-catenin along the A/V axis, being highest in the
most vegetal blastomeres [38]. Nuclear b-catenin acts as a tran-
scription co-activator with Lef1/Tcf1 and it plays a relevant role
is in the vegetal signalling mechanism (VSM) and endomesoderm
formation [39,40].
To examine whether EGFR-like signalling can be involved in the
regulation of b-catenin entering into vegetal nuclei of early cleav-
age stage blastomeres, we examined the spatial distribution of b-
catenin following AG1478 treatment. At the 64-cell stage, control
embryos show a high amount of b-catenin in the nuclei of small
and large micromeres and in veg2 cells, and a progressive decrease
from veg1 cell to upper tiers. Instead, in AG1478-treated embryos,
a reduced level of b-catenin was observed in the nuclei of micro-
meres and veg2 cells, in a dose dependence manner (Fig. 7). These
results suggest that b-catenin nuclearisation requires a functional
EGF receptor-like and this is in agreement with the reduced
endomesoderm in the AG1478-treated embryos (Figs. 4 and 5),
and the enlarged HE pattern shown before (Fig. 6).
The EGFR–ERK signalling pathway is involved in early speciﬁcation
One of the roles of EGFR in several systems is, upon binding to
its ligand, to activate the ERK by phosphorylation. ERKs are serine–Fig. 6. AG1478 alters HE expression along A/V axis. P. lividus embryos cultured with
5 lM (B), 7.5 lM (C), 10 lM (D and D0) of AG1478 at hatching blastula or untreated
(A and A0) incubated with anti-HE. Lateral view is indicated.
Fig. 7. EGFR-like signalling is necessary for b-catenin nuclearisation. Whole mount immunoﬂuorescence of embryos at the 64-cell stage treated with of 5 lM (B), 7.5 lM (C),
10 lM (D) of AG1478 or untreated (A). Animal pole (an), vegetal pole (veg); a schematic representation of the 64-cell stage is shown in A0 , B0 , C0 , D0; small micromeres (s.m.),
large micromeres (l.m.), vegetative 1 (veg1), vegetative 2 (veg2), and mesomere tiers are indicated by the lines.
Fig. 8. EGFR-like signalling effects ERK expression. Immunohistochemistry with
anti-ERK at mesenchyme blastula (A and A0), following AG1478 treatment up to the
7th cleavage stage (B and B0) and up to mesenchyme blastula (C and C0). The em-
bryos are viewed from the side with the animal pole on top unless otherwise me-
ntioned: vv, vegetal view.
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ferent sub-cellular compartments and, in the nucleus, can activatespeciﬁc target genes. The presence of an ERK-like antigen was
demonstrated in P. lividus until second cleavage stage [41]. Further,
it has been demonstrated that a diphosphorylated form of ERK has
a restricted temporal and spatial pattern [42]. It is highly enriched
in PMC precursors at blastula stage and is present until hatching, a
pattern that resembled that shown in Fig. 2 for EGFR. Moreover,
ERK functionality is necessary for micromere ingression, skeleto-
genesis and SMC cell fate. In order to establish whether EGFR is re-
quired for ERK activation we investigated the expression of ERK
after AG1478 treatment using an antibody against the phosphory-
lated form of ERK.
Fertilized eggs were incubated with AG178 and a portion was
washed at the 7th cleavage stage and left to develop until the mes-
enchyme blastula stage, another portion was incubated with the
compound until the mesenchyme blastula stage. Treated embryos
were ﬁxed and stained with the antibody against the activated ERK
(Fig. 8). When the embryos washed at the 7th cleavage stage were
analyzed (8B and B0) the pattern of the stained cells was lower than
in the controls (8A and A0). Instead, the embryos left to develop
with AG1478 until mesenchyme blastula stage showed a large
reduction in ERK staining in the PMC precursors (8C and C0) sug-
gesting that inhibition of EGFR-like strongly prevents its activation.
Discussion
The epidermal growth factor receptor pathway plays a pivotal
role in cell–cell communication and cell proliferation in both ver-
tebrate and invertebrate. Through perturbation experiments, we
have shown that an EGFR-like signalling pathway is required dur-
ing P. lividus embryogenesis. In absence of this signalling, the em-
bryo develops with many defects in the endomesoderm lineage
and in extreme cases shows an animalized phenotype. Further-
more, these results are supported by the evidence that EGFR regu-
lates both the presence of b-catenin in nuclei of the vegetal part
and is responsible for the activation of a related ERK, two types
of molecules that are important for the speciﬁcation of the micro-
mere–PMC lineage.
By spatial and temporal localization of EGFR-like we detected
no speciﬁc distribution throughout cleavage, later in development,
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ciﬁc territories. This kind of localization suggested that EGFR-like
activity could be required for at least two developmental pro-
grams: to regulate the gene expression of maternal determinants
along the A/V axis, and to determine the speciﬁcation of large
micromeres and consequently correct endomesoderm differentia-
tion. It seems that EGFR-like activated by speciﬁc ligands, one of
these could be TGF-a, could give the input for speciﬁc gene net-
work starting. This hypothesis was tested by perturbing embryo
development until the 7th cleavage stage with AG1478, a com-
pound that, as shown, selectively interferes with EGFR phosphory-
lation in a dose-dependent manner. Embryos, left to develop for
48 h, showed morphological defects ranging from mid gastrula to
the most extreme animalized phenotype and in every case with
some problems in gastrulation, spiculogenesis and the production
of pigment cells. Moreover, the extreme animalizing effect after
AG1748 treatment is in agreement with the opposite vegetalizing
effect obtained when EGIP peptides or SfEGF-II, molecules contain-
ing EGF domains, were added to different sea urchin embryo spe-
cies [43,44]. The altered morphology was rescued by TGF-a
treatment. TGF-a has been successfully utilized in rescue experi-
ments in which PDGFR and EGFR antagonists were employed
[25,30]. Different possibilities have been proposed for rescue
mechanism such as recovery of spiculogenesis and gastrulation
by raising of second messengers levels, or by activation of an inte-
grin signalling pathway [30]. Therefore, EGFR-like appears to be re-
quired for signalling before prehatching blastula. Additional
evidence in relation to the effects of the inhibition of EGFR was ob-
tained by immunohistochemistry with territorial markers. Indeed,
we observed that the expression of Ig8 and Endo1, speciﬁc mesen-
chyme and endoderm markers, respectively, were reduced,
whereas expression of EctoV and UH295 antigens, speciﬁc ecto-
derm and ciliary band markers, was unaffected. This is consistent
with the observation that the so called apical ectoderm is autono-
mously speciﬁed and does not require any vegetal signals, in con-
trast to the oral ectoderm territory which is dependent on nuclear
b-catenin [45–47].
The role played by EGFR-like in A/V axis formation was con-
ﬁrmed by monitoring HE gene expression. HE is normally ex-
pressed in an area corresponding to the presumptive ectoderm.
At the 7th cleavage stage, inhibition of EGFR-like by various doses
of AG1478 provokes an enlargement in HE expression territory,
resulting in a progressive extension of the presumptive ectoderm
territory and suggesting that the progeny of the blastomeres from
the vegetal part have had their fates altered towards ectoderm.
This is consistent with the fact that the compound can produce lar-
vae with an animalized phenotype. It has been proposed that HE
can be potentially expressed in all areas of the embryo but it is
negatively controlled in the vegetal area [36]. The data here pre-
sented suggest that signals transduced from EGFR-like might acti-
vate a repressor that acts in the vegetal region of the embryo for
this and other genes.
The activities of micromere progeny are regulated by b-cate-
nin [36,48]. Localization of EGFR-like in micromere descendents
and the morphological effects obtained following AG1478 treat-
ment suggested that it could be responsible, through b-catenin,
for the transmission of the signal necessary in these cells and
to induce signals originating from such cells. At the 7th cleavage
stage, treatment of the embryos with AG1748 results in a de-
crease in b-catenin in the nuclei of derived micromeres. We can-
not exclude that an effect could be a decreased number of
signals sent to veg2 cells with consequent failure of the process
of endomesoderm speciﬁcation. Furthermore, decreased b-cate-
nin in nuclei at the 7th cleavage stage is in agreement with
the enlarged expression of HE in embryos submitted to the same
treatment [36,49].A gene regulatory network (GRN) in which regulatory activator
or repressor elements control spatial gene expression has been
shown to exist for speciﬁcation of sea urchin endoderm and meso-
derm [21]. Presence of GRN seems to be a common requirement for
gene regulation in all bilaterians that can use same regulatory
genes for different purposes [50]. Such regulatory elements can re-
spond to input affected by inter- or intra-cellular signals, and we
cannot exclude that one or more of which might initiate from
EGFR-like [51–53].
Different cell surface stimuli trigger ERK activation and modu-
late a large number of different cellular functions including prolif-
eration, differentiation, survival, migration and adhesion. In sea
urchins, ERK-mediating signalling is required for PMC ingression,
spiculogenesis and mesoderm differentiation [42]. Furthermore,
ERK signalling controls the epithelial–mesenchyme transition
(ETM) of both primary and secondary mesenchyme cells [54].
One of the stimuli activating ERK we supposed came from EGFR
signalling as demonstrated by experiments using AG1748 in which
its presence is down-regulated and PMC ingression and mesoderm
differentiation is affected. Furthermore, ERK activation depends on
a functional TCF/b-catenin pathway [42] and here we have found
that that is altered by AG1748 treatment.
ERK activity is important for the epithelial–mesenchymal tran-
sition (EMT) occurring during critical phases of embryonic devel-
opment. During this phase mesenchyme cells acquire a
morphology that is appropriate for migration in an extracellular
environment. This process permits gastrulation in most metazo-
ans. Many parallels are being found between this process of
embryonic development and tumors [55]. Deregulation of ERK
activity, indeed, contributes to uncontrolled cell proliferation and
neoplastic progression. The results reported here clearly demon-
strate that P. lividus EMT is inhibited when both EGFR-like and
ERK activities are blocked. Hence, sea urchins constitute a good
model system for obtaining information in relation to gene net-
working and the cell signalling involved or altered, even in human
pathology. A molecular understanding of the pathways that control
the development of a given tissue or cell type will also provide the
basis for developing better combination therapies targeting differ-
ent key components of the EGFR signalling network in the respec-
tive cancerous cells.
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